Portfolio (Quarterly)
Guide ↗
Persistent Asset Partners Ltd
· CIK 0002056052| # | Ticker | Company | Sector | Shares | Value ↓ | % Port | Chg Shares | Chg % | Period Price ① | Since Period ① |
|---|---|---|---|---|---|---|---|---|---|---|
| 161 | ADPT | ADAPTIVE BIOTECHNOLOGIES COR | Healthcare | 6,689.0 | $109K | 0.05% | NEW | — | $16.24 | -20.2% |
| 162 | BLTE | BELITE BIO INC | Healthcare | 673.0 | $108K | 0.05% | NEW | — | $159.96 | -10.5% |
| 163 | — | BRIDGEBIO ONCOLOGY THERAPEUT | — | 8,585.0 | $107K | 0.05% | NEW | — | $12.52 | — |
| 164 | — | SURROZEN INC | — | 4,359.0 | $99K | 0.04% | NEW | — | $22.60 | — |
| 165 | EYPT | EYEPOINT INC | Healthcare | 5,387.0 | $98K | 0.04% | NEW | — | $18.27 | -33.1% |
| 166 | XRAY | DENTSPLY SIRONA INC | Healthcare | 8,605.0 | $98K | 0.04% | NEW | — | $11.43 | -11.0% |
| 167 | INSW | INTERNATIONAL SEAWAYS INC | Energy | 2,000.0 | $97K | 0.04% | NEW | — | $48.55 | +73.1% |
| 168 | CSTL | CASTLE BIOSCIENCES INC | Healthcare | 2,463.0 | $96K | 0.04% | NEW | — | $38.90 | -49.7% |
| 169 | ENVA | ENOVA INTL INC | Financial Services | 608.0 | $96K | 0.04% | NEW | — | $157.20 | +4.6% |
| 170 | DNLI | DENALI THERAPEUTICS INC | Healthcare | 5,670.0 | $94K | 0.04% | NEW | — | $16.51 | +13.6% |
| 171 | NVST | ENVISTA HOLDINGS CORPORATION | Healthcare | 4,264.0 | $93K | 0.04% | NEW | — | $21.71 | +7.7% |
| 172 | LBRX | LB PHARMACEUTICALS INC | Healthcare | 4,080.0 | $91K | 0.04% | NEW | — | $22.26 | +36.6% |
| 173 | XGN | EXAGEN INC | Healthcare | 13,230.0 | $80K | 0.04% | NEW | — | $6.08 | -41.6% |
| 174 | — | IBIO INC | — | 39,585.0 | $76K | 0.03% | NEW | — | $1.93 | — |
| 175 | CNTB | CONNECT BIOPHARMA HLDGS LTD | Healthcare | 26,774.0 | $76K | 0.03% | NEW | — | $2.82 | -15.9% |
| 176 | FULC | FULCRUM THERAPEUTICS INC | Healthcare | 6,615.0 | $75K | 0.03% | NEW | — | $11.31 | -40.8% |
| 177 | — | SAB BIOTHERAPEUTICS INC | — | 19,790.0 | $74K | 0.03% | NEW | — | $3.74 | — |
| 178 | SYRE | SPYRE THERAPEUTICS INC | Healthcare | 2,246.0 | $74K | 0.03% | NEW | — | $32.76 | +125.9% |
| 179 | — PUT | BRIDGEBIO PHARMA INC | — | 536.0 | $72K | 0.03% | NEW | — | $134.32 | — |
| 180 | ACRS | ACLARIS THERAPEUTICS INC | Healthcare | 22,259.0 | $67K | 0.03% | NEW | — | $3.01 | +47.5% |
① Period Price is the implied market price on the last day of the reporting period, calculated as reported value ÷ shares held. It is not the fund's purchase price or cost basis — the fund may have initiated or added to the position at any point during the quarter at a different price. Since Period shows the price change from that quarter-end snapshot to today's last price — it reflects stock movement after the report date, not the fund's actual return.
Sector Allocation
Healthcare
56.7%
Technology
14.5%
Financial Services
14.2%
Consumer Cyclical
3.6%
Communication Services
3.5%
Energy
3.5%
Basic Materials
3.0%
Consumer Defensive
0.6%
Industrials
0.4%